Chlorine in PDB 8kfd: Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Enzymatic activity of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
All present enzymatic activity of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy:
1.16.3.1;
Protein crystallography data
The structure of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy, PDB code: 8kfd
was solved by
X.Chen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.30 /
1.80
|
Space group
|
F 4 3 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
183.45,
183.45,
183.45,
90,
90,
90
|
R / Rfree (%)
|
15.3 /
16.6
|
Other elements in 8kfd:
The structure of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy also contains other interesting chemical elements:
Chlorine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
12;
Binding sites:
The binding sites of Chlorine atom in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
(pdb code 8kfd). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 12 binding sites of Chlorine where determined in the
Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy, PDB code: 8kfd:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Chlorine binding site 1 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 1 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl206
b:18.8
occ:0.25
|
NE2
|
A:HIS173
|
3.2
|
23.1
|
1.0
|
CE1
|
A:HIS173
|
4.0
|
25.7
|
1.0
|
CD2
|
A:LEU169
|
4.0
|
18.4
|
1.0
|
CD2
|
A:HIS173
|
4.2
|
20.0
|
1.0
|
CD1
|
A:LEU169
|
4.9
|
18.4
|
1.0
|
|
Chlorine binding site 2 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 2 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl207
b:65.1
occ:1.00
|
O
|
A:HOH512
|
2.2
|
43.6
|
1.0
|
O
|
A:HOH366
|
2.8
|
24.4
|
1.0
|
O
|
A:ARG22
|
2.9
|
17.0
|
0.5
|
O
|
A:ARG22
|
2.9
|
16.8
|
0.5
|
C
|
A:ARG22
|
3.6
|
19.6
|
0.5
|
C
|
A:ARG22
|
3.7
|
19.6
|
0.5
|
O
|
A:HOH309
|
3.7
|
31.1
|
1.0
|
CA
|
A:ARG22
|
3.8
|
16.4
|
0.5
|
CB
|
A:ARG22
|
3.8
|
18.1
|
0.5
|
CA
|
A:ARG22
|
3.8
|
16.4
|
0.5
|
CB
|
A:ARG22
|
3.9
|
18.2
|
0.5
|
O
|
A:HOH362
|
4.0
|
33.4
|
1.0
|
CB
|
A:ASN25
|
4.0
|
14.3
|
1.0
|
OD1
|
A:ASN25
|
4.0
|
17.0
|
1.0
|
N
|
A:LEU26
|
4.1
|
15.3
|
1.0
|
CB
|
A:LEU26
|
4.3
|
15.0
|
1.0
|
CG
|
A:ASN25
|
4.4
|
14.5
|
1.0
|
CG
|
A:ARG22
|
4.5
|
22.8
|
0.5
|
CG
|
A:ARG22
|
4.5
|
22.8
|
0.5
|
CA
|
A:LEU26
|
4.6
|
13.9
|
1.0
|
C
|
A:ASN25
|
4.7
|
15.2
|
1.0
|
CA
|
A:ASN25
|
4.8
|
14.7
|
1.0
|
N
|
A:GLN23
|
4.8
|
15.4
|
1.0
|
CD
|
A:ARG22
|
5.0
|
29.1
|
0.5
|
|
Chlorine binding site 3 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 3 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl208
b:33.3
occ:0.90
|
N
|
A:GLN14
|
3.2
|
17.4
|
1.0
|
CG
|
A:GLN14
|
3.2
|
27.9
|
0.6
|
O
|
A:HOH490
|
3.6
|
39.6
|
1.0
|
CG
|
A:GLN14
|
3.6
|
21.7
|
0.4
|
CB
|
A:GLN14
|
3.8
|
23.3
|
0.6
|
CD2
|
A:HIS13
|
3.8
|
25.1
|
1.0
|
CG
|
A:HIS13
|
3.8
|
23.4
|
1.0
|
CA
|
A:HIS13
|
3.8
|
16.1
|
1.0
|
CB
|
A:GLN14
|
3.9
|
23.7
|
0.4
|
NE2
|
A:HIS13
|
3.9
|
26.5
|
1.0
|
ND1
|
A:HIS13
|
3.9
|
22.0
|
1.0
|
CE1
|
A:HIS13
|
4.0
|
23.5
|
1.0
|
C
|
A:HIS13
|
4.0
|
18.4
|
1.0
|
O
|
A:HOH320
|
4.1
|
55.5
|
1.0
|
CA
|
A:GLN14
|
4.1
|
19.1
|
0.6
|
CA
|
A:GLN14
|
4.1
|
19.1
|
0.4
|
CD
|
A:GLN14
|
4.4
|
29.3
|
0.4
|
CB
|
A:HIS13
|
4.4
|
17.6
|
1.0
|
CD
|
A:GLN14
|
4.5
|
46.5
|
0.6
|
OE1
|
A:GLN14
|
4.5
|
31.8
|
0.4
|
O
|
A:TYR12
|
4.6
|
20.1
|
1.0
|
NE2
|
A:GLN14
|
4.8
|
46.0
|
0.6
|
N
|
A:HIS13
|
5.0
|
15.8
|
1.0
|
|
Chlorine binding site 4 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 4 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl209
b:33.8
occ:0.80
|
O
|
A:HOH483
|
2.7
|
33.7
|
1.0
|
O
|
A:HOH480
|
3.0
|
47.3
|
1.0
|
ND2
|
A:ASN21
|
3.3
|
17.5
|
1.0
|
CB
|
A:ASN21
|
3.9
|
16.5
|
1.0
|
CA
|
A:ALA18
|
3.9
|
16.7
|
1.0
|
CB
|
A:PHE81
|
4.0
|
18.8
|
0.6
|
CD2
|
A:PHE81
|
4.0
|
38.2
|
0.4
|
CG
|
A:ASN21
|
4.1
|
18.8
|
1.0
|
CB
|
A:ALA18
|
4.1
|
17.3
|
1.0
|
CD2
|
A:PHE81
|
4.1
|
28.9
|
0.6
|
CB
|
A:PHE81
|
4.3
|
22.9
|
0.4
|
CG
|
A:PHE81
|
4.3
|
17.8
|
0.6
|
O
|
A:HOH409
|
4.3
|
25.9
|
1.0
|
O
|
A:ALA18
|
4.4
|
17.9
|
1.0
|
CG
|
A:PHE81
|
4.6
|
28.1
|
0.4
|
O
|
A:HOH311
|
4.6
|
43.8
|
1.0
|
C
|
A:ALA18
|
4.7
|
15.9
|
1.0
|
N
|
A:ALA18
|
4.9
|
16.4
|
1.0
|
O
|
A:HOH430
|
4.9
|
29.3
|
1.0
|
O
|
A:HOH468
|
4.9
|
42.1
|
1.0
|
|
Chlorine binding site 5 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 5 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl210
b:29.2
occ:0.70
|
O
|
A:THR135
|
3.0
|
24.1
|
1.0
|
N
|
A:ASN139
|
3.1
|
17.5
|
1.0
|
N
|
A:GLU140
|
3.1
|
18.7
|
0.5
|
N
|
A:GLU140
|
3.1
|
18.7
|
0.5
|
O
|
A:HOH441
|
3.3
|
28.0
|
1.0
|
O
|
A:GLU134
|
3.3
|
23.5
|
0.5
|
O
|
A:HOH431
|
3.4
|
37.0
|
1.0
|
N
|
A:TYR137
|
3.4
|
18.0
|
1.0
|
CB
|
A:ASN139
|
3.5
|
20.4
|
1.0
|
C
|
A:HIS136
|
3.5
|
22.5
|
1.0
|
O
|
A:GLU134
|
3.5
|
23.4
|
0.5
|
C
|
A:THR135
|
3.5
|
25.6
|
1.0
|
CA
|
A:ASN139
|
3.6
|
18.9
|
1.0
|
N
|
A:LEU138
|
3.7
|
17.3
|
1.0
|
C
|
A:TYR137
|
3.7
|
18.3
|
1.0
|
CG
|
A:GLU140
|
3.7
|
23.6
|
0.5
|
C
|
A:ASN139
|
3.8
|
19.4
|
1.0
|
O
|
A:HIS136
|
3.9
|
21.0
|
1.0
|
N
|
A:HIS136
|
3.9
|
16.6
|
1.0
|
CA
|
A:HIS136
|
4.0
|
15.9
|
1.0
|
CA
|
A:TYR137
|
4.0
|
17.5
|
1.0
|
C
|
A:LEU138
|
4.1
|
17.0
|
1.0
|
CB
|
A:GLU140
|
4.1
|
22.4
|
0.5
|
CB
|
A:GLU140
|
4.1
|
22.4
|
0.5
|
O
|
A:TYR137
|
4.1
|
19.3
|
1.0
|
CA
|
A:GLU140
|
4.2
|
20.8
|
0.5
|
CA
|
A:GLU140
|
4.2
|
20.8
|
0.5
|
C
|
A:GLU134
|
4.4
|
21.8
|
0.5
|
CA
|
A:LEU138
|
4.4
|
15.8
|
1.0
|
C
|
A:GLU134
|
4.5
|
21.8
|
0.5
|
O
|
A:HOH385
|
4.5
|
33.7
|
1.0
|
CA
|
A:THR135
|
4.5
|
20.1
|
1.0
|
O
|
A:HOH356
|
4.6
|
42.0
|
1.0
|
CD
|
A:GLU140
|
4.7
|
31.8
|
0.0
|
OE2
|
A:GLU140
|
4.7
|
36.9
|
0.5
|
O
|
A:HOH500
|
4.8
|
41.9
|
1.0
|
CG
|
A:ASN139
|
4.8
|
25.4
|
1.0
|
N
|
A:THR135
|
4.9
|
19.6
|
1.0
|
O
|
A:ASN139
|
4.9
|
18.0
|
1.0
|
|
Chlorine binding site 6 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 6 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl211
b:26.8
occ:0.80
|
O
|
A:HOH410
|
2.5
|
32.8
|
1.0
|
O
|
A:HOH470
|
2.9
|
42.8
|
1.0
|
NE2
|
A:GLN75
|
3.1
|
23.1
|
1.0
|
CG
|
A:GLN75
|
3.8
|
19.5
|
1.0
|
CD
|
A:GLN75
|
3.9
|
27.1
|
1.0
|
NZ
|
A:LYS71
|
4.1
|
33.7
|
0.5
|
CE
|
A:LYS71
|
4.2
|
30.9
|
0.5
|
CE
|
A:LYS71
|
4.3
|
31.1
|
0.5
|
NZ
|
A:LYS71
|
4.8
|
34.4
|
0.5
|
|
Chlorine binding site 7 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 7 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 7 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl212
b:24.9
occ:0.80
|
OE1
|
A:GLN83
|
2.7
|
25.9
|
0.0
|
N
|
A:ASP84
|
3.2
|
14.7
|
1.0
|
OD1
|
A:ASP84
|
3.6
|
19.6
|
1.0
|
CG
|
A:ASP84
|
3.6
|
20.8
|
1.0
|
CB
|
A:GLN83
|
3.6
|
19.5
|
0.5
|
CA
|
A:GLN83
|
3.6
|
19.1
|
0.5
|
CA
|
A:GLN83
|
3.7
|
19.1
|
0.5
|
CB
|
A:GLN83
|
3.7
|
19.4
|
0.5
|
CD
|
A:GLN83
|
3.8
|
26.1
|
0.0
|
OD2
|
A:ASP84
|
3.9
|
20.2
|
1.0
|
C
|
A:GLN83
|
3.9
|
16.9
|
0.5
|
C
|
A:GLN83
|
3.9
|
16.9
|
0.5
|
CG
|
A:GLN83
|
4.0
|
24.6
|
0.5
|
CB
|
A:ASP84
|
4.0
|
16.3
|
1.0
|
CA
|
A:ASP84
|
4.2
|
12.8
|
1.0
|
CG
|
A:GLN83
|
4.3
|
22.4
|
0.5
|
CD
|
A:GLN83
|
4.5
|
29.8
|
0.5
|
O
|
A:HOH370
|
4.6
|
17.2
|
0.9
|
O
|
A:HOH325
|
4.6
|
21.8
|
0.5
|
NE2
|
A:GLN83
|
4.6
|
43.1
|
0.5
|
CA
|
A:CA205
|
4.7
|
23.9
|
0.3
|
O
|
A:HOH363
|
4.8
|
23.8
|
1.0
|
NE2
|
A:GLN83
|
4.9
|
39.3
|
0.5
|
|
Chlorine binding site 8 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 8 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 8 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl213
b:48.1
occ:0.90
|
N
|
A:ASN11
|
3.0
|
18.9
|
1.0
|
CA
|
A:GLN10
|
3.8
|
15.7
|
1.0
|
CL
|
A:CL216
|
3.8
|
25.4
|
0.8
|
C
|
A:GLN10
|
3.9
|
20.3
|
1.0
|
CA
|
A:ASN11
|
3.9
|
15.7
|
1.0
|
CG
|
A:GLN10
|
4.1
|
25.5
|
1.0
|
CB
|
A:GLN10
|
4.5
|
17.2
|
1.0
|
CB
|
A:ASN11
|
4.7
|
18.4
|
1.0
|
O
|
A:ARG9
|
4.9
|
19.2
|
1.0
|
N
|
A:GLN10
|
4.9
|
15.9
|
1.0
|
|
Chlorine binding site 9 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 9 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 9 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl214
b:32.0
occ:0.25
|
CE1
|
A:HIS173
|
3.6
|
25.7
|
1.0
|
ND1
|
A:HIS173
|
4.3
|
25.9
|
1.0
|
NE2
|
A:HIS173
|
4.5
|
23.1
|
1.0
|
O
|
A:HOH427
|
4.8
|
41.9
|
1.0
|
|
Chlorine binding site 10 out
of 12 in 8kfd
Go back to
Chlorine Binding Sites List in 8kfd
Chlorine binding site 10 out
of 12 in the Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 10 of Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl215
b:27.4
occ:0.80
|
ND2
|
A:ASN139
|
3.4
|
20.8
|
1.0
|
O
|
A:HOH487
|
3.5
|
49.5
|
1.0
|
CD
|
A:LYS143
|
3.8
|
22.2
|
1.0
|
O
|
A:HOH347
|
3.9
|
26.5
|
1.0
|
CG
|
A:LYS143
|
4.1
|
19.6
|
1.0
|
OD1
|
A:ASN139
|
4.1
|
21.6
|
1.0
|
CG
|
A:ASN139
|
4.2
|
25.4
|
1.0
|
|
Reference:
B.Jiang,
X.Chen,
K.Fan.
Ferritin Drug Carrier(Fdc) For Encapsulated Platinum (IV) Prodrug For Esophageal Squamous Cell Carcinoma Targeted Therapy To Be Published.
Page generated: Tue Jul 30 11:05:39 2024
|